Acute ischemic stroke in cancer patients. A case-control study

Autor: Pedro E. Colla Machado, Agustín Pappolla, Claudia Alonzo, Laura Brescacin, Alejandra N. Heriz, Andrea Horsch, Idaira Payares Utria, Federico Anrriquez, Federico Sosa Albacete, María B. Justich, Natalia R. Balian, María C. Zurrú
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Medicina (Buenos Aires), Vol 80, Iss 5, Pp 442-446 (2020)
ISSN: 1669-9106
0025-7680
Popis: One in 10 patients with ischemic stroke has comorbid cancer. Our goal was to compare stroke patients with cancer against those without cancer in terms of clinical and radiological features, and the underlying mechanism. We conducted a retrospective case-control study in patients admitted with ischemic stroke between July 2013 and September 2018. Cases had a concomitant diagnosis of cancer and acute ischemic stroke, controls only of ischemic stroke. Age, gender, vascular risk factors (VRF), pattern of ischemic lesion in neuroimaging, etiology and clinical outcome were compared between groups. Fifty-seven cases were identified, 61% were male (n = 35), and mean age was 75 ± 11. Fiftytwo had known oncologic disease at the onset of stroke. Most of them had solid tumors (91%, n = 52), and 54% (n = 31) had a non-metastatic tumor at the time of stroke. Prevalence of common VRF between groups was not significantly different. Previous deep venous thrombosis and pulmonary thromboembolism were more frequent in the cancer cohort (8% vs. 1%, p = 0.01). The average NIHSS was 3.8 ± 4 in the cancer group and 9 ± 7 in the control group (p = 0.01). Small artery disease as the etiology of stroke was significantly less common in the cancer group (2% vs. 26%, p = 0.001). Regarding neuroimaging, the embolic pattern was more frequent in patients with cancer (82% vs. 35%, p = 0.001). In these patients recurrence and mortality at 90 days was three and six times higher (10% vs. 3%, and 18% vs. 3%. p = 0.08 and 0.001, respectively).
Databáze: OpenAIRE
Externí odkaz: